Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present.
about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismA prospective stratified case-cohort study on statins and multiple adverse events in Japan.Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression.Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.Pharmacogenetics: potential role in the treatment of diabetes and obesityRetrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia.Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook.Investigation of predictors of increased creatine kinase levels following vascular surgery and the association with peri-operative statin therapy.Molecular mechanisms of pharmaceutical drug binding into calsequestrin.Inflammatory myopathy associated with statins: report of three cases.A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial.Statin-associated adverse cognitive effects: survey results from 171 patients.Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline.The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis.Prevalence and risk factors of muscle complications secondary to statins
P2860
Q24603957-3C3B0955-44E3-4378-BFFE-03FDB57B6185Q33584216-4868B05D-EA15-4EE9-95F7-5567FB849F65Q35174188-13FA92B1-FDDC-4A94-A697-121980A72BF9Q35232279-BA009132-5BA9-429C-ACA7-A32FDB42073EQ37142047-02CB0DE5-E639-44D6-BAA4-839E6EAD7932Q37540885-C83F9E30-619D-44A1-87AB-C0C9846D2AFDQ37690832-6D577F36-3D6F-49CF-B7A4-85F0C611E08CQ38113494-EAF2709E-299B-4F5F-818C-CB501062D4F9Q38651225-D4A6DF50-DD63-4344-BE7D-3EB91B0200F1Q42115774-DC3F84E3-DFD3-4121-A6C5-E4BE15FBA9D6Q42277029-076281F0-C67F-4703-B7CD-D2CA1A470ACBQ42706490-780D71DD-6042-4F5A-9E97-5BAB92591E6EQ45913969-94C9CFB2-5E90-4BB4-964A-8EF20AE6E63BQ46011754-D233AD31-434F-478C-A1F2-D19EE51DB0F9Q47336691-12DCADB7-3561-43F9-A0E5-32BC203ADC60Q47697200-D1F35428-A6B0-484C-A3A5-5BA68C809FC1Q57312174-D317D663-ABA5-4BFA-B9B2-9AC0ACB7FF04
P2860
Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Systematic review and meta-ana ...... orldwide from 1982 to present.
@ast
Systematic review and meta-ana ...... orldwide from 1982 to present.
@en
type
label
Systematic review and meta-ana ...... orldwide from 1982 to present.
@ast
Systematic review and meta-ana ...... orldwide from 1982 to present.
@en
prefLabel
Systematic review and meta-ana ...... orldwide from 1982 to present.
@ast
Systematic review and meta-ana ...... orldwide from 1982 to present.
@en
P2093
P2860
P356
P1476
Systematic review and meta-ana ...... orldwide from 1982 to present.
@en
P2093
David L McClure
John E Hokanson
Morton Glanz
Robert J Valuck
P2860
P304
P356
10.1002/PDS.1341
P577
2007-02-01T00:00:00Z